SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062077
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:20
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-20231109.htm   iXBRL 8-K 55717
2 EX-99.1 adpt-ex99_1.htm EX-99.1 331486
3 GRAPHIC img119828894_0.jpg GRAPHIC 7887
  Complete submission text file 0000950170-23-062077.txt   534911

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adpt-20231109_pre.xml EX-101.PRE 10687
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adpt-20231109.xsd EX-101.SCH 2495
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adpt-20231109_lab.xml EX-101.LAB 17020
8 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20231109_htm.xml XML 4544
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 231392622
SIC: 2836 Biological Products, (No Diagnostic Substances)